A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220203 Method and composition for potentiating an opiate analgesic
11/04/2004	US20040220180 Compositions relating to novel compounds and targets thereof
11/04/2004	US20040220153 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220143 Oral delivery of macromolecules
11/04/2004	US20040220136 bioavailability of cobalamin; mixture with cytokine; controlling gene expression of protein
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220131 administering an oligonucleotide antibody to reduce concentration of clustenin
11/04/2004	US20040220129 Compositions and methods for siRNA inhibition of ICAM-1
11/04/2004	US20040220128 Nucleic acid based modulation of female reproductive diseases and conditions
11/04/2004	US20040220126 hepatocyte growth factor gene as drug; topical applying ; side effect reduction; cardiovascular disorders
11/04/2004	US20040220123 therapy for bactericide infections which are drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acids;
11/04/2004	US20040220122 Administering teichoplanin; remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection
11/04/2004	US20040220113 Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions
11/04/2004	US20040220111 administering polypeptide in mixturte with carrier; topical applying surface of body; wound healing agents; tissue repair
11/04/2004	US20040220110 Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/04/2004	US20040220109 controlling dietetic fats and,or antilipemic agents ; reducing blood lipid concentration
11/04/2004	US20040220108 Neo-tryptophan
11/04/2004	US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004	US20040220106 Modified vitamin K-dependent polypeptides
11/04/2004	US20040220105 glucagon-like peptide in gek form; antidiabetic agents
11/04/2004	US20040220104 Meconium aspiration syndrome treatments
11/04/2004	US20040220103 administering tumor necrosis factor receptor antagonist; prevent drug resistance; Gaucher's disease; Huntington's disease, muscular dystrophy
11/04/2004	US20040220102 injecting tissue growth factor or cell differentiation factor into spinal canal or disk for therapy; mixture of calcium chloride and thrombin; bone morphogenic protein
11/04/2004	US20040220101 Method of treating disc herniation and disc degeneration with concentrated growth and differentiation factors
11/04/2004	US20040220099 Polypeptides selectively expressed in fat tissue and methods for use thereof
11/04/2004	US20040220098 Inhibin compositions and methods of enhancing fertility and growth
11/04/2004	US20040220097 Drug screening for compounds that modulate the function of anti-apoptotic protein Bcl-2 to induce apoptosis; identifying antitumor agents
11/04/2004	US20040220096 Method and compositions for treating dopaminergic and gabanergic disorders
11/04/2004	US20040220094 Inverse agonist and agonist peptides that stimulate/inhibit hair growth
11/04/2004	US20040220093 Bacteriocins and novel bacterial strains
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220090 Advanced glycation end-product intermediaries and post-amadori inhibition
11/04/2004	US20040220089 Ophthalmic preparation containing glycoprotein
11/04/2004	US20040220088 Multiple domain glycoprotein hormones and methods of using
11/04/2004	US20040220087 antiinflammatory agents; anticancer agents; ulitization phosphate acceptor compound; phosphoprotein
11/04/2004	US20040220086 contacting with protein which binds to cells in diseased tissue; antitumor agents
11/04/2004	US20040220085 Compositions for nucleic acid delivery
11/04/2004	US20040220083 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body
11/04/2004	US20040220082 Parkinson's disease; central nervous system disorders; reducing activation of Kv3.4 protein
11/04/2004	US20040220080 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
11/04/2004	US20040220079 Inhibitors of Memapsin 2 and use thereof
11/04/2004	US20040219671 RNA interference mediated treatment of parkinson disease using short interfering nucleic acid (siNA)
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
11/04/2004	US20040219633 Method of producing recombinant antibodies
11/04/2004	US20040219632 T1r3 a novel taste receptor
11/04/2004	US20040219619 Methods of identifying compounds that alter toxin persistence and/or protease activity
11/04/2004	US20040219615 Antibody specific for a RAP-2 (RIP associated protein-2)of given sequence; mediating intracellular activity by introducing into cell DNA sequence encoding polypeptide in the form of a vector
11/04/2004	US20040219597 Using cytokeratin marker peptides as diagnostic, prognostic and treatment tools for inflammations and/or infections in animals or humans; sepsis prevention; veterinary medicine
11/04/2004	US20040219591 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
11/04/2004	US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004	US20040219555 Method of determining susceptibility to inflammatory bowel disease
11/04/2004	US20040219551 Comprises nucleotide sequences coding epithelial stromal interaction 1 (EPSTI-1) protein for use in tumor diagnosis and identifying modulators for treatment of cell prolifefrative and viral disorders
11/04/2004	US20040219521 Nucleotide sequences for use as tools in disease diagnostics, forensics, gene mapping, mutation identification and to assess biodiversity
11/04/2004	US20040219514 Caml-binding peptides
11/04/2004	US20040219236 Composition and method for reducing post-prandial blood glucose
11/04/2004	US20040219232 Methods and compounds for treating malabsorption diseases and inflammatory conditions of the gastrointestinal tract
11/04/2004	US20040219207 Drug preparation comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases
11/04/2004	US20040219204 Method of treating angiogenic tissue growth
11/04/2004	US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004	US20040219172 In situ administering botulinum toxins
11/04/2004	US20040219165 Streptococcus pneumoniae antigens
11/04/2004	US20040219162 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
11/04/2004	US20040219160 Zwitterionic immunomodulators for the treatment of asthma and allergy
11/04/2004	US20040219153 Synergistic tumorcidal response induced by histamine
11/04/2004	US20040219152 Methods for modulating angiogenesis with apelin compositions
11/04/2004	US20040219151 Tetraspan protein and uses thereof
11/04/2004	US20040219150 Uses of mammalian cytokine; related reagents
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219147 administering an anti-inflammatory compound, especially an antibody to a complement component or an NSAID, to a subject receiving a stent in connection with percutaneous transluminal coronary angioplasty.
11/04/2004	US20040219146 Prevention and treatment of amyloidogenic disease
11/04/2004	US20040219145 Compositions and methods to modulate immune and inflammatory responses
11/04/2004	US20040219140 Compositions and methods for preventing platelet aggregation
11/04/2004	US20040219134 implantation or attachment of an engineered three-dimensional stromal tissue to promote endothelialization and angiogenesis in the heart and related tissues
11/04/2004	US20040219133 cells are dispersed using an air-jet sprayer after being suspended in a soluble media either directly onto the area or onto a tissue scaffold to form three dimensional epithelial tissue
11/04/2004	US20040219131 Interferon-alpha polypeptides and conjugates
11/04/2004	US20040219130 Hyperthermia agent for malignant tumor comprising cytokine and magnetic fine particles
11/04/2004	US20040219129 Pharmaceutical composition for preventing or treating ischemic diseases
11/04/2004	US20040219102 Compositions for drug delivery
11/04/2004	US20040219096 Enhancing interferon gamma production using interleukin 27; treating immune and proliferative disorders
11/04/2004	US20040217055 purified; fatty acids removed; efficiency, low cost
11/04/2004	DE10317935A1 Use of casein for prevention or treatment of Helicobacter infections and associated diseases prevents adhesion of bacteria to the mucosa and oxidizes iron
11/04/2004	DE10005433B4 Biomaterialien Biomaterials
11/04/2004	CA2563312A1 Plasmid mediated ghrh supplementation for renal failures
11/04/2004	CA2528503A1 Tolerance to graft prior to thymic regeneration
11/04/2004	CA2526915A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2526887A1 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b
11/04/2004	CA2523459A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004	CA2523358A1 Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections
11/04/2004	CA2523260A1 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
11/04/2004	CA2523197A1 Peptide vectors
11/04/2004	CA2522904A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/04/2004	CA2522891A1 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
11/04/2004	CA2522819A1 Polyvalent protein complex
11/04/2004	CA2522758A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
11/04/2004	CA2522751A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/04/2004	CA2522718A1 A novel method of modulating bone-related activity

1 ... 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 ... 3163